SEC Form 4 · accession 0001179110-16-022758
YIELD10 BIOSCIENCE, INC. · YTEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Johan van Walsem
Officer — Chief Operating Officer
Period of report
Apr 1, 2016
Accepted (ET)
Apr 5, 2016 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001121702
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3 | Apr 1, 2016 | F | 17,969 | $1.86 | D | 268,491 | D | |
| Common StockF2,F3 | holding | — | — | — | 8,447 | I | By 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld in payment of withholding taxes upon vesting of RSUs granted 4/1/15.
- F2Shares acquired as Company matching contributions under the Metabolix, Inc. 401(k) Plan.
- F3The shares of Common Stock reported herein give effect to the 1-for-6 reverse stock split which became effective in accordance with the terms of the Certificate of Amendment to the Company's Amended and Restated Certificate of Incorporation filed with the Secretary of State of Delaware on May 26, 2015.